HUTCHMED (China) Limited - ADR earnings per share and revenue
On --, HCM reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were HUTCHMED (China) Limited - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, HUTCHMED (China) Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to HUTCHMED (China) Limited - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is HUTCHMED (China) Limited - ADR expected to report next?
The next earning report is scheduled for 17 de mar. de 2026.
What are the forecasts for HUTCHMED (China) Limited - ADR's next earnings report?
Based on --
analistas, HUTCHMED (China) Limited - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.